Natco Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524816	NSE Symbol:	NATCOPHARM	P/E :	10.79
ISIN Demat:	INE987B01026	Div & Yield %:	0.66	EPS :	84.75
Book Value:	461.80	Market Cap (Rs. Cr.):	16,385.87	Face Value :	2

Date	Headline
02-Dec-25	Natco Pharma announces change in senior management
29-Nov-25	Natco Pharma receives affirmation in credit ratings from ICRA
21-Nov-25	Natco Pharma concludes USFDA inspection of its API unit in Chennai
14-Nov-25	Board of Natco Pharma recommends interim dividend
10-Nov-25	Natco Pharma to conduct board meeting
31-Oct-25	Natco Pharma launches Everolimus tablets 1mg
25-Sep-25	Board of Natco Pharma considers demerger of agro biz
18-Sep-25	Natco Pharma successfully concludes USFDA inspection of its pharma division unit at Kothur
01-Sep-25	Natco Pharma to convene AGM
20-Aug-25	Natco Pharma launches Bosentan tablets for oral suspension, 32 mg

Company Snapshot